Navigation Links
Approval of Safer Alternative to Pradaxa Delayed by FDA
Date:6/26/2012

Dallas, TX (PRWEB) June 26, 2012

The Pradaxa Resource Center, a patient advocacy group, is alerting patients who have suffered internal bleeding after taking the drug Pradaxa that the release of a safer alternative to the drug has been delayed by an FDA decision.

For now, anyone who has suffered internal bleeding after taking Pradaxa is encouraged to speak with their doctor about their options and to a lawyer about their legal rights as soon as possible.

Pradaxa is an anticoagulant medication prescribed to patients with atrial fibrillation in order to prevent strokes. The Wall Street Journal reported on April 24, 2012, that the drug already reached the $1 billion blockbuster sales mark for the 12-month period ending in February.

Unfortunately, several reports have identified risks with the drug. The FDA warned on December 7, 2011 that it was looking into the safety of Pradaxa after receiving higher than expected reports of injury or death. Most recently, the Institute for Safe Medication Practices reported on June 6, 2012 that Pradaxa led all other medications in 2011 for number of death and bleeding reports to the FDA.

Now, Reuters has reported on June 25th that the FDA is delaying the approval of Eliquis, a rival anticoagulant to Pradaxa developed by Bristol-Myers Squibb Co and Pfizer Inc. According to the article, the new drug will be marketed as a safer alternative to Warfarin since many cardiologists are no longer comfortable prescribing Pradaxa.

Due to the number of people affected by Pradaxa internal bleeding, lawyers have asked that the large number of expected lawsuits be consolidated into one central federal court. The Pradaxa lawsuit is known as Case MDL No. 2385 IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

The Pradaxa Resource Center believes that the consolidation of Pradaxa lawsuits into one court will expedite the litigation process and help victims share in valuable evidence. However, due to the specialized nature of these federal MDL cases, only certain lawyers can help.

Anyone affected by Pradaxa side effects is urged to speak with a lawyer about their legal options. The Pradaxa Resource center works only with lawyers who are already handling Pradaxa lawsuits.

For more information on the research, warnings, pradaxa side effects and legal options relating to the drug Pradaxa, or to speak with a lawyer, visit http://www.Pradaxa-lawsuits.org.

Read the full story at http://www.prweb.com/releases/pradaxa/bleeding-lawsuits/prweb9640132.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. U.S. Bests Canada, Europe in Drug Approvals
2. Tafamidis: Approval denotes proven added benefit
3. Human factors researcher pushes for safer gas fireplaces
4. Safer Grilling Methods Might Cut Cancer Risk
5. Planting the right messages may make farms safer
6. OHSU Oregon National Primate Research Center develops new, safer method for making vaccines
7. Safer kidney cancer surgery under-used for poorer, sicker Medicare, Medicaid patients
8. Less-Invasive Surgery for Esophageal Cancer Might Be Safer
9. Study Supports Value of Sigmoidoscopy, an Alternative to Colonoscopy
10. Procedure gives patients with A-fib who cant take blood thinners alternative to reduce stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... , ... February 20, 2017 , ... ... Constellation Brands to purchase a new ultrasound-enhanced thrombolysis machine, a state-of-the-art device that ... gift was facilitated by the Pepin Family Foundation. , “We greatly appreciate this ...
(Date:2/19/2017)... Viejo, CA (PRWEB) , ... February 19, 2017 , ... ProBrand Glitch is a set ... . With ProBrand Glitch users can easily reveal any logo with a glitch reveal in ... X users control over the style and animation of each preset. Use these presets to ...
(Date:2/18/2017)... , ... February 17, 2017 ... ... for Devicemakers , Sponsored by Axendia, **FDAnews Free Webinar**, March 1, 2017 ... manufacturers looking to reduce their regulatory burden? Pay dividends in enhanced and ...
(Date:2/18/2017)... ... 17, 2017 , ... CONTACT:, Glenn Vallecillos, MD, FACS, +1 ... Dr. Glenn Vallecillos experiments SculpSure, the hot, new, aesthetic, non-surgical procedure ... been centered around that idea that to achieve ones desired results a surgical ...
(Date:2/18/2017)... ... February 18, 2017 , ... ... the latest information and contact points to easily connect elderly veterans of America's ... living, and elder-care funding. It also conveys material on this year's increase in ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... , Feb. 20, 2017  National Decision Support ... integrate the company,s CareSelect Imaging platform within the ... agreement sets the technical foundation for MEDITECH sites, ... CareSelect Imaging Clinical Decision Support Mechanism through the ... directly with and support the integration of NDSC,s ...
(Date:2/20/2017)... 2017  Today from HIMSS17, Ambra Health , ... announced the launch of  Ambra for Developers ... around modern, RESTful web-services, this is the first cloud ... With these new APIs, IT departments at health systems ... into other applications such as population health or reporting ...
(Date:2/20/2017)... 20, 2017  There has been a paradigm shift ... across sub-Saharan Africa, which in turn is driving the ... more Western lifestyle diseases such as cardiovascular disease (CVD), ... and parasitic illness, will present the pharmaceutical industry in ... of $40.8 billion in 2019. "An increase ...
Breaking Medicine Technology: